Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Debt / NOTE 1.500% 6/1
-
Market price (% of par)
-
88.54%
-
Total 13F principal
-
$174,660,250
-
Principal change
-
-$24,918,750
-
Total reported market value
-
$155,061,380
-
Number of holders
-
19
-
Value change
-
-$26,716,158
-
Number of buys
-
11
-
Number of sells
-
11
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 as of Q3 2024
As of 30 Sep 2024,
IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 was held by
19 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$174,660,250
in principal (par value) of the bond.
The largest 10 bondholders included
BRAIDWELL LP, DeepCurrents Investment Group LLC, D. E. Shaw & Co., Inc., Indaba Capital Management, L.P., Calamos Advisors LLC, Verition Fund Management LLC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, ARISTEIA CAPITAL, L.L.C., AGF MANAGEMENT LTD, and CITIGROUP INC.
This page lists
19
institutional bondholders reporting positions
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.